Speech-Language Pathologists in Winnetka, IL Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Megan Paolucci, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 312-780-0820

Karen Nelson Tzanetopoulos, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Woodley Mnr, Winnetka, IL 60093 Phone: 847-446-0059

Mary Geiser Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 312-780-0820

Kelly Lukanich, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 312-780-0820

Lisa June Yee Leung, M.S., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 877-780-0820

Amanda Schultz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 312-780-0820

Katelyn G Kluckman, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 000-000-0000

Erin Vollmer, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave, Ste 4b, Winnetka, IL 60093 Phone: 312-780-0820

Shelby Lynne Thelen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 545 Lincoln Ave Ste 4, Winnetka, IL 60093 Phone: 312-780-0820

News Archive

Researcher finds link between social disadvantage and mental illness among people in northern India

A survey of nearly 1000 households in the north Indian state of Uttarakhand showed that six percent of adults were identified as depressed.

Interim results from QLT's Phase 1b study of QLT091001 for Leber congenital amaurosis

QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.

Newly discovered mechanism may be useful target to stop flu virus from infecting cells

There's a hitch in the swing of a protein that delivers the flu virus. Rice University and Baylor College of Medicine researchers believe this mechanism may be a useful target to stop the virus from infecting cells.

HCSA Annual Conference sponsored by PENTAX Medical to focus on new health procurement strategy

PENTAX Medical is a key sponsor of this year's Health Care Supply Association Annual Conference and Exhibition, which takes place in Manchester, 13-14 November. One of the keynote speakers – Peter Smith – will be presenting the PENTAX Medical sponsored talk entitled: "The new health procurement strategy – a commentator and supplier view", which takes place on Thursday 14th November, at 9am.

Novo Nordisk introduces NovoRapid PumpCart insulin pump

Today, Novo Nordisk launches NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains NovoRapid (insulin aspart) – a rapid-acting insulin from Novo Nordisk – is expected to make insulin pump therapy more convenient for people with diabetes and their care staff.

Read more Medical News

› Verified 4 days ago